Southern Asia: Antisera Market 2024

Antisera Market Size in Southern Asia

In 2021, the South Asian antisera market decreased by -8% to $X for the first time since 2011, thus ending a nine-year rising trend. Over the period under review, consumption, however, saw a prominent expansion. The level of consumption peaked at $X in 2020, and then dropped in the following year.

Antisera Production in Southern Asia

In value terms, antisera production shrank modestly to $X in 2021 estimated in export price. Overall, production recorded resilient growth. The pace of growth appeared the most rapid in 2013 when the production volume increased by 31% against the previous year. The level of production peaked at $X in 2020, and then dropped in the following year.

Antisera Exports

Exports in Southern Asia

Antisera exports skyrocketed to X tons in 2021, jumping by 142% on the year before. In general, exports saw a prominent expansion. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, antisera exports reached $X in 2021. Overall, exports continue to indicate a significant increase. The most prominent rate of growth was recorded in 2018 when exports increased by 113%. The level of export peaked in 2021 and is expected to retain growth in the near future.

Exports by Country

India dominates exports structure, reaching X tons, which was near 98% of total exports in 2021. Sri Lanka (X tons) held a minor share of total exports.

Exports from India increased at an average annual rate of +18.7% from 2012 to 2021. At the same time, Sri Lanka (+53.3%) displayed positive paces of growth. Moreover, Sri Lanka emerged as the fastest-growing exporter exported in Southern Asia, with a CAGR of +53.3% from 2012-2021. From 2012 to 2021, the share of Sri Lanka increased by +1.8 percentage points.

In value terms, India ($X) remains the largest antisera supplier in Southern Asia, comprising 99% of total exports. The second position in the ranking was taken by Sri Lanka ($X), with a 0.5% share of total exports.

In India, antisera exports increased at an average annual rate of +26.7% over the period from 2012-2021.

Export Prices by Country

The export price in Southern Asia stood at $X per ton in 2021, with a decrease of -53.1% against the previous year. Over the period under review, the export price, however, posted a buoyant increase. The growth pace was the most rapid in 2018 an increase of 47%. The level of export peaked at $X per ton in 2019; however, from 2020 to 2021, the export prices stood at a somewhat lower figure.

Prices varied noticeably country of origin: the country with the highest price was India ($X per ton), while Sri Lanka stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Sri Lanka (+22.5%).

Antisera Imports

Imports in Southern Asia

In 2021, purchases abroad of antisera and other blood fractions decreased by -2.9% to X tons for the first time since 2017, thus ending a three-year rising trend. Overall, imports, however, posted a significant expansion. The most prominent rate of growth was recorded in 2020 with an increase of 62%. As a result, imports attained the peak of X tons, and then reduced slightly in the following year.

In value terms, antisera imports fell markedly to $X in 2021. In general, imports, however, recorded a resilient increase. The pace of growth appeared the most rapid in 2020 with an increase of 61% against the previous year. As a result, imports attained the peak of $X, and then reduced sharply in the following year.

Imports by Country

India prevails in imports structure, finishing at X tons, which was approx. 84% of total imports in 2021. It was distantly followed by Bangladesh (X tons), creating a 6.6% share of total imports. The following importers - Sri Lanka (X tons), Nepal (X tons) and Bhutan (X tons) - each reached a 6.5% share of total imports.

Imports into India increased at an average annual rate of +25.4% from 2012 to 2021. At the same time, Bhutan (+50.8%), Bangladesh (+11.2%) and Nepal (+5.0%) displayed positive paces of growth. Moreover, Bhutan emerged as the fastest-growing importer imported in Southern Asia, with a CAGR of +50.8% from 2012-2021. Sri Lanka experienced a relatively flat trend pattern. India (+23 p.p.) and Bhutan (+1.6 p.p.) significantly strengthened its position in terms of the total imports, while Nepal, Bangladesh and Sri Lanka saw its share reduced by -5.8%, -7.5% and -11% from 2012 to 2021, respectively.

In value terms, India ($X) constitutes the largest market for imported antisera and other blood fractions in Southern Asia, comprising 89% of total imports. The second position in the ranking was taken by Bangladesh ($X), with a 4.7% share of total imports. It was followed by Sri Lanka, with a 2.8% share.

From 2012 to 2021, the average annual growth rate of value in India amounted to +9.6%. In the other countries, the average annual rates were as follows: Bangladesh (+6.6% per year) and Sri Lanka (-3.0% per year).

Import Prices by Country

The import price in Southern Asia stood at $X per ton in 2021, declining by -19.7% against the previous year. Overall, the import price continues to indicate a deep contraction. The pace of growth appeared the most rapid in 2019 when the import price increased by 5.4%. Over the period under review, import prices reached the peak figure at $X per ton in 2012; however, from 2013 to 2021, import prices remained at a lower figure.

Prices varied noticeably country of destination: the country with the highest price was Sri Lanka ($X per ton), while Nepal ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Nepal (-0.4%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :